GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.29B
Enterprise Value 32.08B
Trailing P/E 91.07
Forward P/E 136.64
PEG Ratio (5 yr expected) 12.65
Price/Sales (ttm)5.80
Price/Book (mrq)8.35
Enterprise Value/Revenue 35.27
Enterprise Value/EBITDA 653.41

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 6.52%
Operating Margin (ttm)7.61%

Management Effectiveness

Return on Assets (ttm)6.62%
Return on Equity (ttm)11.20%

Income Statement

Revenue (ttm)394.11M
Revenue Per Share (ttm)11.03
Quarterly Revenue Growth (yoy)19.60%
Gross Profit (ttm)272.14M
EBITDA 38.87M
Net Income Avi to Common (ttm)25.68M
Diluted EPS (ttm)0.68
Quarterly Earnings Growth (yoy)374.20%

Balance Sheet

Total Cash (mrq)209.79M
Total Cash Per Share (mrq)5.68
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.60
Book Value Per Share (mrq)7.42

Cash Flow Statement

Operating Cash Flow (ttm)76.56M
Levered Free Cash Flow (ttm)42.53M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.21
52-Week Change 392.26%
S&P500 52-Week Change 38.62%
52 Week High 392.18
52 Week Low 331.05
50-Day Moving Average 370.64
200-Day Moving Average 371.51

Share Statistics

Avg Vol (3 month) 3485.38k
Avg Vol (10 day) 3546.97k
Shares Outstanding 536.9M
Float 24.92M
% Held by Insiders 12.77%
% Held by Institutions 186.93%
Shares Short (Mar 29, 2019) 42.54M
Short Ratio (Mar 29, 2019) 44.34
Short % of Float (Mar 29, 2019) 412.42%
Short % of Shares Outstanding (Mar 29, 2019) 46.89%
Shares Short (prior month Feb 28, 2019) 41.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A